Iradimed (IRMD) Capital Expenditures (2013 - 2026)

Iradimed (IRMD) has 14 years of Capital Expenditures data on file, last reported at $403000.0 in Q1 2026.

• On a quarterly basis, Capital Expenditures fell 89.1% year-over-year to $403000.0 in Q1 2026; TTM through Mar 2026 was $4.5 million, a 61.1% decrease from a year earlier, with the FY2025 full-year figure at $7.8 million, down 3.0% from the prior year.
• Capital Expenditures for Q1 2026 stood at $403000.0, up from $294174.0 in the prior quarter.
• Over the last five years, Capital Expenditures for IRMD reached as high as $6.4 million in Q2 2023 and fell as low as -$6.3 million in Q4 2023.
• Historically, Capital Expenditures has averaged $1.0 million across 5 years, with a median of $308086.0 in 2023.
• On a YoY basis, Capital Expenditures climbed as much as 3314.64% in 2023 and fell as far as 2556.83% in 2023.
• Year by year, Capital Expenditures stood at $258136.0 in 2022, then sank by 2556.83% to -$6.3 million in 2023, then soared by 144.0% to $2.8 million in 2024, then plunged by 89.46% to $294174.0 in 2025, then surged by 36.99% to $403000.0 in 2026.
• Per Business Quant data, the three most recent Capital Expenditures figures were $403000.0 in Q1 2026, $294174.0 in Q4 2025, and $1.1 million in Q3 2025.